• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

TELEPERFORMANCE

Notes

No. Proposition For Against Abstain
1

Approval of the statutory financial statements for the year ended December 31, 2025

2

Approval of the consolidated financial statements for the year ended December 31, 2025

3

Appropriation of 2025 results - Determination of dividend amount and payment date

4

Special report of the statutory auditors on regulated agreements and commitments for the 2025 financial year - Acknowledgment of the absence of new agreements in 2025

5

Approval of the regulated agreement entered into between Teleperformance SE and Mr. Jorge Amar

6

Approval of the information referred to in paragraph I of Article L. 22-10-9 of the French Commercial Code for all of the Company's corporate officers

7

Acknowledgement and approval, where necessary, of the absence of any remuneration element (fixed, variable or exceptional) and of any benefit of all kind paid in the 2025 financial year or granted in respect of the 2025 financial year to Mr. Moulay Hafid ELALAMY, Chairman of the Board of Directors

8

Approval of the fixed, variable and exceptional elements comprising the total remuneration and the benefits of all kind paid in the 2025 financial year or granted in respect of the 2025 financial year to Mr. Daniel JULIEN, Chief Executive Officer

9

Approval of the fixed, variable and exceptional elements comprising the total remuneration and the benefits of all kind paid in the 2025 financial year or granted in respect of the 2025 financial year to Mr. Thomas MACKENBROCK, Deputy Chief Executive Officer

10

Approval of the fixed, variable and exceptional elements comprising the total remuneration and the benefits of all kind paid in the 2025 financial year or granted in respect of the 2025 financial year to Mr. Thomas MACKENBROCK, Deputy Chief Executive Officer

11

Approval of the remuneration policy for Directors

12

Approval of the remuneration policy for the Chairman of the Board of Directors

13

Approval of the remuneration policy for the Chief Executive Officer from January 1, 2026 to March 15, 2026 inclusive

14

Approval of the remuneration policy for the Chief Executive Officer starting March 16, 2026

15

Approval of the remuneration policy for the Deputy Chief Executive Officer

16

Approval of the remuneration policy for the Deputy Chief Executive Officer in charge of finance

17

Ratification of the provisional appointment of Ms. Ingrid JOHNSON as a director

18

Renewal of the term of office of Ms. Ingrid JOHNSON as a director

19

Ratification of the provisional appointment of Ms. Hanadi Nasser K. A. AL-THANI as a director

20

Renewal of the term of office of Ms. Hanadi Nasser K. A. AL-THANI as a director

21

Ratification of the provisional appointment of Mr. Thomas MACKENBROCK as a director

22

Renewal of the term of office of Mr. Thomas MACKENBROCK as a director

23

Appointment of Mr. Moulay M Hamed ELALAMY, as a director, to replace Mr. Varun BERY

24

Ratification of the provisional appointment of Mr. Jorge AMAR as a director

25

Authorization to be given to the Board of Directors to allow the Company to repurchase its own shares pursuant to the provisions of Article L.22-10-62 of the French Commercial Code, duration of the authorization, purposes, conditions, cap, non-exercise during public offerings

26

Amendment of Article 16 of the Articles of Association in order to provide for the possibility to use the written consultation of the members of the Board of Directors

27

Update of Article 25.1 of the Articles of Association with the provisions of Article R. 22-10-28 of the French Commercial Code

28

Powers for formalities